Jim Shaw

Jim Shaw

Company: Chimeric Therapeutics

Job title: Director, Analytical Development


Panel Discussion: Developing Assays Suitable for Release Testing 11:30 am

What is the best strategy to minimise panels for release? Are there certain assays that should be removed How do we minimise release testing to reduce chances of method failure, while ensure the product is still safe and efficacious?Read more

day: Day 2 Track 2 AM

Panel Discussion: Early Stage Characterization & Analysis of Cellular Therapeutics 2:30 pm

What is the best strategy to characterize cell therapies when their dynamism makes it impossible to fully characterize all properties and functions? Given each assay only reveals a limited number of attributes, how many assays do we need to fully characterize our cell products? How do we select the most appropriate cellular attribute?Read more

day: Day 1 Track 1 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.